There were 420 press releases posted in the last 24 hours and 150,291 in the last 365 days.

Veterinary Vaccines Market Share to Reach $8.6 billion with 6.2% CAGR Forecast to 2022

Veterinary Vaccines Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2022

PUNE, INDIA, September 16, 2016 / -- The Global Veterinary Vaccines Market accounted for $5.3 billion in 2014 and is expected to grow at a CAGR of 6.2% to reach $8.6 billion by 2022. The factors driving the veterinary vaccines market include rising zoonotic diseases, growing incidence of animal diseases, increasing investments by government and welfare associations. However, factors such as increasing adoption of vegetarian food in prominent economies and increasing costs of storage and maintenance of vaccines are hindering the market growth. Growing awareness of animal health in emerging economies and technological innovations are likely to create opportunities for veterinary vaccines market in the coming years.

Complete report details @

The Global veterinary vaccines market is segmented on the basis of diseases, technologies and geography. On the basis of diseases, the veterinary vaccine market is segmented into companion animal diseases (respiratory, gastrointestinal and reproductive tracts), poultry diseases (bronchitis, avian influenza, newcastle disease and marek's disease), porcine diseases (porcine reproductive disease, swine pneumonia and swine influenza) and equine diseases (rhinopneumonitis, influenza and encephalomyelitis). By technologies, the market is categorized into toxoid vaccines, DNA vaccines, recombinant vaccines, live attenuated vaccines (LAV) and inactivated vaccines. By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. However, Asia is expected to register a higher growth rate during the forecast period owing to huge investment opportunities in this region.

Request a sample report @

Some of the key players in the veterinary vaccine market include Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.)., Boehringer Ingelheim (Germany), Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Heska Co. (U.S.), Ceva Animal Health, Inc. and Virbac.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @

Table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Veterinary Vaccines Market, By Diseases
5.1 Introduction
5.2 Companion animal diseases
5.2.1 Respiratory diseases
5.2.2 Gastrointestinal diseases
5.2.3 Reproductive diseases
5.3 Poultry diseases
5.3.1 Bronchitis
5.3.2 Avian influenza
5.3.3 Newcastle disease
5.3.4 Marek's disease
5.4 Porcine diseases
5.4.1 Porcine reproductive disease
5.4.2 Swine pneumonia
5.4.3 Swine influenza
5.5 Equine diseases
5.5.1 Rhinopneumonitis
5.5.2 Influenza
5.5.3 Encephalomyelitis

6 Global Veterinary Vaccines Market, By Technologies
6.1 Introduction
6.2 Toxoid vaccines
6.3 DNA vaccines
6.4 Recombinant vaccines
6.5 Live attenuated vaccines
6.6 Inactivated vaccines

7 Global Veterinary Vaccines Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia
7.4 Rest of the World
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Zoetis (U.S.)
9.2 Merck Animal Health (U.S.)
9.3 Merial Inc. (Sanofi) (France)
9.4 Elanco Animal Health (U.S.).
9.5 Boehringer Ingelheim (Germany)
9.6 Bayer Healthcare (Germany)
9.7 Bioniche Animal Health (Canada)
9.8 Heska Co. (U.S.)
9.9 Ceva Animal Health, Inc.
9.10 Virbac

Buy this report @

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here